| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | LILLY ELI & CO | 667,050 | 49,062,000 | 9.23% | ||
| 2 | BAXTER INTL INC | 952,833 | 42,249,000 | 7.95% | ||
| 3 | ABBOTT LABS | 976,590 | 37,511,000 | 7.06% | ||
| 4 | PERKINELMER INC | 623,408 | 32,511,000 | 6.12% | ||
| 5 | IRONWOOD PHARMACEUTICALS INC COM CL A | 1,972,678 | 30,162,000 | 5.67% | ||
| 6 | BOSTON SCIENTIFIC CORP | 1,255,580 | 27,158,000 | 5.11% | ||
| 7 | BRISTOL MYERS SQUIBB CO | 449,290 | 26,257,000 | 4.94% | ||
| 8 | GILEAD SCIENCES INC | 359,290 | 25,729,000 | 4.84% | ||
| 9 | SHIRE PLC | 146,961 | 25,039,000 | 4.71% | ||
| 10 | VERTEX PHARMACEUT | 333,950 | 24,602,000 | 4.63% | ||
| 11 | INTEGRA LIFESCIENCES HLDGS CP COM NEW | 281,207 | 24,125,000 | 4.54% | ||
| 12 | MASIMO CORP COM | 313,004 | 21,096,000 | 3.97% | ||
| 13 | BIO RAD LABS INC CL A | 114,042 | 20,788,000 | 3.91% | ||
| 14 | ANTHEM INC | 140,810 | 20,244,000 | 3.81% | ||
| 15 | MERCK & CO INC | 283,410 | 16,684,000 | 3.14% | ||
| 16 | MCKESSON CORP | 115,200 | 16,180,000 | 3.04% | ||
| 17 | PATTERSON COS INC | 386,232 | 15,847,000 | 2.98% | ||
| 18 | Momenta Pharmaceuticals Inc | 855,265 | 12,872,000 | 2.42% | ||
| 19 | CIGNA CORPORATION | 95,270 | 12,708,000 | 2.39% | ||
| 20 | UNITED THERAPEUTICS | 67,974 | 9,750,000 | 1.83% | ||
| 21 | LIFEPOINT HOSPS INC | 164,714 | 9,356,000 | 1.76% | ||
| 22 | EXELIXIS INC | 520,091 | 7,755,000 | 1.46% | ||
| 23 | OWENS & MINOR INC NEW | 214,172 | 7,558,000 | 1.42% | ||
| 24 | IMPAX LABORATORIES INC | 499,153 | 6,614,000 | 1.24% | ||
| 25 | ALEXION PHARMACEUTIC | 48,500 | 5,934,000 | 1.12% | ||
| 26 | TENET HEALTHCARE CORP | 252,080 | 3,741,000 | 0.70% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001475373-17-000001, filed 2017.02.14).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
